CBP-CON-00178

Active
Federal

GRIFOLS AUSTRALIA PTY LTD

Awarded by National Blood Authority

National Blood Authority has a limited-tender contract with Grifols Australia Pty Ltd worth AU$891,884,206 for a national supply arrangement of imported immunoglobulin products from December 2020 to December 2027. The procurement was exempt under TR 10.3.d.iii due to an absence of competition for technical reasons, and the contract has one amendment.

$891.9M
Contract Value

Contract Details

Reference
CN3743075
Jurisdiction
Federal
Financial Year
FY26
Category
Drugs and Pharmaceutical(UNSPSC: 51000000)

Description

National Supply arrangement for imported immunoglobulin products

Key Dates

Publish Date
9 June 2026
Effective Date
31 Dec 2020
End Date
30 Dec 2027

Published fields

Procurement method
Limited tender
Location
Not published in this source

Supplier

GRIFOLS AUSTRALIA PTY LTD

ABN
35 050 104 875

Agency

National Blood Authority

ABN
87 361 602 478

Contract History

This contract has been amended 1 time.

Original Contract
Published 19 Jan 2021
$607.7M
Amendment A1
Current
Published 9 June 2026
$891.9M